Skip to content 
At present, there are patients with various fundus diseases in ChinaMore than 40 millionMore than 3 million new patients with fundus diseases are added every yearFundus diseases are not only diverseAnd most of them have greater damage to visual functionIn severe cases, blindness can occur
Jiangning High-tech Zone EnterpriseNanjing Boshi Medical Technology Co., LtdSelf-developed onesRank light ® fundus intelligent navigation laser Recently obtainedIssued by the National Medical Products Administration Class III Medical Device Registration Certificate.
At the same time, the company was evaluatedDepartment of Science and Technology, Ministry of Industry and Information TechnologyDepartment of Medical Device Registration, National Medical Products Administration“Artificial intelligence medical device innovation tasksUnveiling the winners”Its “ophthalmic all-solid-state laser photocoagulation instrument”(aka: Zhiguang ® fundus intelligent navigation laser)Successfully selected as “Intelligent Assisted Therapy Product”.
Rank light ® fundus intelligent navigation laser
® The intelligent navigation laser of the fundus is mainly used for the laser photocoagulation treatment of fundus diseases.
The product uses advanced real-time image acquisition technology, so that doctors can directly observe and shoot real-time ultra-wide-angle fundus images through the screen without relying on traditional slit lamp microscopes, and can carry out AI-assisted digital treatment plan planning based on fundus color photos or images from other diagnostic equipment, including the location of laser treatment, spot size, interval and protection area.
Combined with high-speed eye tracking and intelligent navigation technology, the device is able to direct the laser directly to a preset position, enabling intelligent, fast and precise automatic laser treatment.
® The intelligent navigation laser not only solves many pain points of traditional slit lamp laser treatment, but also has significant advantages such as intelligence, speed and accuracy.
With the integration of 5G technology, the device can also realize remote laser treatment, which will help the further sinking of fundus laser photocoagulation technology, improve the accessibility of high-quality medical resources in China, and benefit tens of millions of fundus patients.
Boshi Medical
It is an ophthalmology innovation platform company for all ages, committed to providing innovative solutions for the diagnosis and treatment of fundus diseases, the prevention and control of myopia in adolescents, functional contact lenses, ophthalmic digital medicine and customized scientific research equipment.
Up to now, the company has independently developed a variety of advanced equipment, and has been approved 4 medical device product registration certificates.
○ Star Lens ® Adaptive Optics Fundus Imaging System (Su Machinery Alignment 20242160025) is the “world’s first” commercial-grade non-invasive in vivo high-resolution retinal imaging system based on AO-SLO technology (innovative medical device product);
○ Zhiguang ® fundus intelligent navigation laser (National Machinery Zhuzhu 20243161449) is the “first in China, the only one in the world” laser treatment equipment with real-time high-definition large field of view images, high-speed eye tracking, artificial intelligence surgical assisted planning, precision automatic laser and other innovative functions.
○In addition, there is also a multi-modal, high-resolution, ultra-wide-angle ophthalmic imaging scientific research instrument for small animals, Haojing ® Small Animal Multi-mode Ophthalmic Imaging System, which has also been successfully launched and delivered.
Since 2021, the Ministry of Industry and Information Technology and the State Drug Administration have jointly launched the unveiling of artificial intelligence medical device innovation tasks, with a total of 1,035 declared projects across the country, and a total of 221 project teams with good team foundation, high clinical value and strong technical strength have been shortlisted for the unveiling stage.
After two years of in-depth research and development, a total of 104 companies finally stood out and were awarded the “Winners of the Artificial Intelligence Medical Device Innovation Task Unveiling List”.
From the declaration to the unveiling, and then to the acquisition of the registration certificate, every step embodies the hard work and persistent pursuit of excellence of the Boshi medical team, and also shows the scientific and technological innovation achievements of Jiangning enterprises.
As the main position of the biomedical and new medical device industry in Jiangning District, Jiangning High-tech Zone is also an important core of the “two cores and three poles” planning and layout of Nanjing’s biomedical industry.
After years of jointing growth, at present, the biomedical and new medical device industry in Jiangning High-tech Zone is entering the harvest period, and related products are listed one after another. So far this year, 11 drugs and 4 devices have been launched in the park, demonstrating the effectiveness of cultivating and developing new quality productivity.
